309 results on '"Moxley, R. A."'
Search Results
2. Exercise Intolerance and Muscle Pain in Myotonic Disorders
3. Myotonic dystrophy type 2 (DM2) and related disorders: Report of the 180th ENMC Workshop including guidelines on diagnostics and management 3–5 December 2010, Naarden, The Netherlands
4. Location of Phosphotyrosine-Containing Proteins by Immunocytochemistry in the Rat Forebrain Corresponds to the Distribution of the Insulin Receptor
5. QUANTITATIVE ANALYSIS OF THE “WARM-UP” PHENOMENON in MYOTONIC DYSTROPHY TYPE 1
6. A CLINICAL STUDY OF THE PERCEPTION AND PRIORITIZATION OF COGNITIVE SYMPTOMS IN MYOTONIC DYSTROPHY TYPE-1 (DM1): 18
7. SUB-REGIONAL DUAL-ENERGY X-RAY ABSORPTIOMETRY (DEXA) ANALYSIS: A POTENTIAL ENDPOINT MEASURE FOR THERAPEUTIC TRIALS IN MYOTONIC DYSTROPHY TYPE 1 (DM1): 10
8. DNA Affinity Chromatography of Transcription FactorsThe Oligonucleotide Trapping Approach
9. Hypothyroid neuropathy and myopathy: clinical and electrodiagnostic longitudinal findings
10. Effects of dietary fiber and distillers grains on fecal shedding of enterohemorrhagic Escherichia coli in feedlot steers
11. Consensus-based care recommendations for adults with myotonic dystrophy type 1
12. A study of enterohemorrhagic Escherichia coli in beef cow-calf herds in Mississippi and Nebraska
13. Survival patterns and cancer determinants in families with myotonic dystrophy type 1
14. Cross‐sectional study to estimate the prevalence of enterohaemorrhagic Escherichia coli on hides of market beef cows at harvest
15. A four‐season longitudinal study of enterohaemorrhagic Escherichia coli in beef cow–calf herds in Mississippi and Nebraska
16. Effects of dietary fiber and distillers grains on fecal shedding of enterohemorrhagic Escherichia coli in feedlot steers
17. Effects of dietary fiber and distillers grains on enterohemorrhagic Escherichia coli hide contamination prior to slaughter in feedlot steers
18. Prevalence of EHEC-7 on hides of market beef cattle at slaughter
19. study of enterohemorrhagic Escherichia coli in beef cow-calf herds in Mississippi and Nebraska
20. A randomized controlled trial to evaluate the effects of dietary fibre from distillers grains on enterohemorrhagic Escherichia coli detection from the rectoanal mucosa and hides of feedlot steers
21. Pigmentation phenotype, photosensitivity and skin neoplasms in patients with myotonic dystrophy
22. Survival patterns and cancer determinants in families with myotonic dystrophy type 1.
23. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy (DM) types 1 and 2
24. Risk factors in beef cattle for terminal rectal mucosa colonization of Escherichia coli 0157:H7
25. Factors affecting Escherichia coli 0157:H7 hide contamination of feedlot cattle
26. Effects of dietary fiber and distillers grains on enterohemorrhagic Escherichia coli hide contamination prior to slaughter in feedlot steers
27. Prevalence of EHEC-7 on hides of market beef cattle at slaughter
28. 372 Evaluation of the value of fiber in distillers grains plus solubles on performance of finishing cattle
29. A randomized controlled trial to evaluate the effects of dietary fibre from distillers grains on enterohemorrhagic <italic>Escherichia coli</italic> detection from the rectoanal mucosa and hides of feedlot steers.
30. Factors affecting Escherichia coli 0157:H7 hide contamination of feedlot cattle
31. Risk factors in beef cattle for terminal rectal mucosa colonization of Escherichia coli 0157:H7
32. Effects of media type on Shiga toxigenic E. coli growth patterns
33. A Longitudinal Study to Describe the Presence of Escherichia coli 0157:H7 and Salmonella spp in Feedlot Cattle Pens
34. A Longitudinal Study of the Prevalence, Incidence and Duration of Fecal Shedding of Escherichia coli 0157:H7 by Feedlot Cattle
35. Pen-level prevalence and Environmental Risk Factors for Escherichia coli 0157:H7 Fecal Shedding by Feedlot Cattle
36. Stochastic Simulation Model Comparing Distributions of STEC O157 Faecal Shedding Prevalence Between Cattle Vaccinated With Type III Secreted Protein Vaccines and Non-Vaccinated Cattle
37. Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1.
38. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1)
39. Symptoms of Myotonia as Reported by Patients with Myotonic Dystrophy Type 1: Location, Description and Severity- Implications for Clinical Trials (P05.184)
40. Results from a National Cross-Sectional Study of Disease-Burden in Facioscapulohumeral Muscular Dystrophy (FSHD) (S15.004)
41. Video Hand Opening Time (vHOT) in Myotonic Dystrophy Type 1 (DM1) (P05.188)
42. Correlation between Biomarkers and Surrogate Markers in Patients with Myotonic Dystrophy Type 1 (DM-1): Data from the Study of Pathogenesis and Progression in DM (STOPP DM) (P05.185)
43. Relationships between Upper Extremity Strength and the Purdue Pegboard Test and the Jebsen-Taylor Hand Function Test in Patients with Myotonic Dystrophy Type 1 (P05.187)
44. Wide-area measurements to improve system models and system operation
45. Protective relay traveling wave fault location
46. Low-impedance bus differential - security and reliability in complex bus arrangements
47. Weekend high-dosage prednisone: A new option for treatment of Duchenne muscular dystrophy
48. Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1
49. Case studies: Synchrophasor WAMPAC maximizes stability and economy
50. Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.